Funds holding IO BIOTECH INC
1 fund declares a position · 0 ETFs and 1 other funds · 11.6K $ · US4497781090
Each line carries its report date.
| Rank | Fund | Shares | Value | Weight | |
|---|---|---|---|---|---|
| 1 | Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 33,307 | 11.6K $ | 0.00 % | as of Feb 28, 2026 · Original filing |
Institutional managers
12 managers declare this company to the SEC (Form 13F). These positions are not counted in the totals above: a manager and its own funds file separately.
| Manager | Shares | Value | |
|---|---|---|---|
| Ikarian Capital, LLC | 1,386,565 | 81.4K $ | as of Mar 31, 2026 |
| BOOTHBAY FUND MANAGEMENT, LLC | 451,852 | 26.5K $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 301,291 | 18.1K $ | as of Mar 31, 2026 |
| XTX Topco Ltd | 265,792 | 15.6K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 206,215 | 12.1K $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 194,158 | 11.4K $ | as of Mar 31, 2026 |
| CITIGROUP INC | 72,495 | 4.3K $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 57,974 | 3.4K $ | as of Mar 31, 2026 |
| Beacon Pointe Advisors, LLC | 42,600 | 2.5K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 33,307 | 2K $ | as of Mar 31, 2026 |
| UBS Group AG | 30,977 | 1.8K $ | as of Mar 31, 2026 |
| GSA CAPITAL PARTNERS LLP | 348,352 | 20 $ | as of Mar 31, 2026 |